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Food safety is a major and persistent threat to the nutritional status of populations globally 
and is increasingly jeopardizing the effectiveness of public health programs. The burden of 
foodborne disease (FBD), estimated to be of the same order of magnitude as the burden of 
the “big three” (malaria, HIV/AIDS, and tuberculosis), is expected to be further exacerbated 
by the ongoing pandemic and its impact on food systems globally. Our progress toward the 
2nd United Nations Sustainable Development Goal (SDG) to “end hunger, achieve food 
security and improved nutrition and promote sustainable agriculture” by 2030 may not be 
realized if we do not ensure food safety across the value chains to provide safe and nutrient-
rich food to a growing global population.  
Unsafe food can cause a variety of acute and chronic health impacts ranging from mild to 
debilitating or even life-threatening. In addition to increased morbidity and mortality, unsafe 
food results in significant socioeconomic impacts through healthcare costs and lost 
productivity, as well as harm to trade.  There is evidence that foodborne disease also impacts 
outcomes that are also associated with nutrition, such as stunting and wasting. However, data 
on this component of the FBD burden and its underlying mechanisms are far from complete. 
Individuals in low-resource settings are considered to be particularly vulnerable to the effects 
of foodborne disease and associated nutrition impacts. However, more complete and 
accurate epidemiological data are needed to truly assess the impacts of foodborne diseases 
and their association with health and nutrition outcomes. 
The aim of this report is to provide an overview of cross-pathways linking food 
safety/foodborne illness and nutrition and their shared impacts on health, while highlighting 
research gaps and opportunities for intervention. This body of evidence is meant to support 
the development of a framework linking food safety and nutrition, as part of Feed the Future 
and EatSafe programming.   
The review specifically focuses on the health implications of food safety on nutrition-relevant 
outcomes. In this context, food safety includes acute and long-term physiological impacts. 




growth, and development outcomes, as well as outcomes related to metabolic and perinatal 
development.  
The literature search was carried out in PubMed using an a priori developed search strategy, 
complemented by additional resources (CGIAR, CYMMIT, ICRISAT, FAO, IFPRI, WHO, World 
Bank). Where available, we leveraged information from existing reviews in lieu of original 
research articles. The review covers the connections between foodborne hazards and 
nutrition-relevant outcomes, including in the context of vulnerable populations. The 
Discussion contextualizes findings and highlights research gaps and limitations.  
We identified clear linkages between some foodborne hazards and nutrition-related 
outcomes. However, the reviewed evidence does not allow for a clear attribution of causality. 
For instance, a strong relationship between gastrointestinal illness and growth impairment in 
children has been documented, but the extent of this impact and the underlying mechanisms 
are incompletely understood. Our findings also indicate a negative impact of certain hazards 
on nutrient absorption, growth outcomes, and metabolic functions. However, many of the 
reviewed studies have methodological limitations that can impede the ability to compare and 
contextualize findings within and between study populations. Nevertheless, we found some 
evidence for increased vulnerability to adverse nutrition outcomes from foodborne disease 
in specific populations including children, food handlers, women, pregnant women, and the 
elderly. Overall, additional research is warranted to effectively understand underlying 
mechanisms and potential group-specific interventions in more detail. 
We found little evidence for the impact of pharmacological treatments of foodborne disease 
on nutritional outcomes, which may in part be due to limitations in our search strategy. 
Associations of antimicrobial treatment with diarrhea have been reported, while other 
evidence indicate a growth-promoting effect. Nausea can be a side effect of antiamebic and 
anthelmintic treatments; however, it is unclear whether and to what extent this affects 
nutrient intake and long-term nutrition outcomes.  
In conclusion health-based connections between food safety and nutrition exist but are 
complex and often difficult to disentangle. Addressing existing data gaps on foodborne 




be to harmonize measures and metrics for research protocols used for investigating this topic. 
In addition, longitudinal studies with frequent follow-ups could allow for a more granular 
assessment and potential attribution of health outcomes to a specific food hazard. 
1. INTRODUCTION 
Current estimates from the Global Nutrition Report indicate that one in three people 
worldwide are affected by malnutrition, which can broadly include features indicative of 
undernutrition, poor micronutrient status, or overweight and obesity. Increasingly, evidence 
is also suggesting a double burden of malnutrition in many of these individuals where 
undernutrition coexists with overweight, obesity and other diet-related non-communicable 
diseases (1). This double burden of malnutrition creates unique societal challenges with 
potential negative impacts on health-care costs, productivity, and economic growth, 
particularly in low-resource populations (2). 
Nutritional insults (e.g. inadequate micro- or macro-nutrient supply) during certain life stages 
may have both short-term and long-term consequences, including intergenerational effects. 
Tackling malnutrition in all its forms requires that nutritional needs are addressed through 
the entire life-course (2). With diet-related factors consistently ranked as the top modifiable 
risk factor for morbidity and mortality worldwide, it is critical to understand and intervene on 
any challenge to diet and nutrition, including food safety. During the current COVID-19 
pandemic, an even greater number of people may be affected by further food shortages, 
foodborne threats, and nutrition challenges. 
Unsafe food creates a vicious cycle of disease and malnutrition, which particularly affects 
infants, young children, elderly, and the sick (3). Ensuring food safety is critical for optimal 
nutrition and health, and effective food safety management at the national level involves 
multiple stakeholders operating under diverse environmental, infrastructural, and socio-
political conditions (4). Threats to food safety can occur at any stage of the value chain from 
production to consumption and can range from contamination with pathogens or toxins to 




The World Health Organization (WHO) defines foodborne disease as “a disease commonly 
transmitted through ingested food. FBDs [Foodborne diseases] comprise a broad group of 
illnesses, and may be caused by microbial pathogens, parasites, chemical contaminants and 
biotoxins” (5). In 2010, 31 foodborne hazards (including 11 diarrheal disease agents, 7 invasive 
infectious disease agents, 10 helminths, 3 chemicals) combined were responsible for 600 
(95% uncertainty interval, UI: 420 – 960) million episodes of foodborne illnesses and 420 000 
(UI: 310 000 – 600 000) deaths in addition to 33 million disability adjusted life years (DALYs). 
Data for 5 additional hazards of importance (4 bacterial, 1 chemical), were only available for 
subregions and did not allow for global estimates (5). 
Symptoms associated with foodborne disease are manifold and range from mild and self-
limiting (e.g. nausea, vomiting, diarrhea) to debilitating and life-threatening (e.g. kidney and 
liver failure, brain and neural disorders, paralysis, and potentially cancers), and can lead to 
long periods of absenteeism and premature death (5). The highest foodborne disease burden 
is seen in LMICs in Africa, South-East Asia, and the Eastern Mediterranean, this considerable 
gap between low- and high-income regions suggests that a major proportion of the foodborne 
disease burden is avoidable (5).  
Access to safe food is key to allow individuals to benefit from its nutritional benefits. While it 
is generally accepted that compromised food safety is detrimental to the health of individuals 
or even populations, the linkages between a lack of food safety and nutrition outcomes are 
poorly understood and not quantified. The “chicken and egg” lack of data and adequate 
metrics and measures also hinders progress towards a quantification of this burden. This is 
particularly concerning given the broad impact on the food supply chain and often chronic 
health consequences of unsafe food in addition to its socioeconomic impacts.  
In this review, we aim to synthesize the available knowledge and provide an overview of main 
physiological pathway linking foodborne illness to nutrition outcomes, also in the context of 
vulnerable populations. In the Discussion section we contextualize and discuss findings, 
highlight evidence gaps, and provide suggestions for future research directions. A pictorial 






Figure 1. Illustration of key nutrition-relevant outcomes considered in the review. 
2. METHODS  
2.1. Outcomes of interest 
Outcomes of interest, for the purposes of this review, are mainly physiological impacts of food 
safety on nutrition outcomes (Table 1).  
 
Table 1. Food safety and nutrition outcomes considered in this review. 
Food safety and foodborne disease 
Health outcomes Physiological manifestation of foodborne disease (e.g. 
gastrointestinal illness), acute and long-term 
Nutrition-related outcomes 
Food consumption Adequate intake of nutritious food and ability to properly digest it 
Nutrient absorption Micronutrient absorption and deficiency, ability to assimilate food 






Newborn growth, placental/fetal development, gestational 
diabetes, preeclampsia and its impacts 
Other outcomes E.g. gastric cancer, metabolic diseases such as type 2 diabetes 
mellitus, overweight/obesity, thyroid disease 
2.2. Literature search protocol 
This review aims to identify and describe linkages between food safety and nutrition-related 
outcomes. A key objective is to synthesize the available evidence on food safety in the context 
of nutrition outcomes, to identify evidence gaps, and make recommendations for policy 
makers and researchers to fill those gaps.  
We reviewed the food safety literature and identified studies through a search strategy that 
was developed a priori in collaboration with an experienced librarian. The search was 
completed in PubMed and retrieved an initial set of 8336 non-duplicate items. Titles and 
abstracts in this initial set were screened by one reviewer. Of all identified titles and abstracts, 
276 full texts were screened. Reasons for exclusion included absence of links to nutrition 
outcomes, reports describing laboratory experiments or single outbreaks, and studies and 
reviews focusing exclusively on behavioral or economic factors. Systematic reviews were 
considered whether or not they focused on outcomes in LMICs. This search strategy was 
complemented by a review of articles from selected relevant resources (CIAT, CGIAR, 
CIMMYT, IFPRI, ILRI, WHO, World Bank, World fish). Furthermore, we screened reference lists 
of relevant articles to identify relevant literature that was not captured by the search strategy. 
Where available, we included evidence synthesized in identified (systematic) literature 
reviews in lieu of primary research articles. A total of 86 studies were included in the review.  
3. RESULTS 
Our search revealed 52 articles from the linkages between foodborne disease and 
physiological outcomes that we considered relevant for inclusion in this review, including 26 





 3.1 Physiological impacts of foodborne disease on nutritional outcomes 
 
The largest body of evidence directly linking food safety to nutrition and health outcomes 
pertains to foodborne illness, though most of it is from high-income settings. We considered 
a total of 51 articles in this section. Of those, 26 were systematic reviews (with or without 
meta-analyses), nine reviews (non-systematic), as well as seven articles other articles 
(primary research, burden of disease, risk assessment, or policy documents). Different 
hazards may elicit physiological mechanisms and consequently affect nutrition outcomes via 
different pathways, summarized in Tables 2, 3, and 4. Evidence is strong for a relationship 
between gastrointestinal illness and growth impairment; however, the extent of this 
relationship and underlying mechanisms are not well understood. The synthesized evidence 
also suggests a negative impact of certain hazards on nutrient absorption (e.g. helminths, 
Helicobacter pylori), growth outcomes (e.g. mycotoxins, arsenic), metabolic functions such as 
glucose and thyroid metabolism (e.g. persistent organic pollutants and other chemicals), as 
well as gastrointestinal ulcers (Helicobacter pylori). In addition to short-term consequences, 
foodborne diseases can have a variety of long-term health implications. These consequences 
are manifold and include impaired growth and development, cognitive decline, as well as 
negative impacts on reproductive and metabolic processes.  
 
3.1.1. Impact of foodborne gastrointestinal illness 
Diarrhea 
Diarrhea is the most common manifestation of food borne disease caused by microbial 
hazards, and results from excessive secretion and/or impaired absorption of fluid and 
electrolytes across the intestinal epithelium. Undernourished or unwell children are at a 
higher risk of subsequent infection and mortality compared to healthy ones, which may result 
in a bi-directional positive feedback loop in which childhood undernutrition and diarrhea each 
increase the risk of the other (6). A systematic review conducted in 2018 on the etiology of 
gastroenteritis and acute diarrhea among children <5 years of age reports that viruses 
accounted for the majority (50.2%) of cases followed by bacteria (31.6%), and parasites 




regions followed by Escherichia coli (15.6%) and Adenovirus (10.8%), with Giardia lamblia 
(7.3%) being the most prevalent parasite (7).  
Environmental enteropathy (environmental enteric dysfunction) 
Environmental enteropathy describes a reversible subclinical state of intestinal inflammation 
in response to enteric pathogens. It is characterized by gut mucosal cell villous atrophy, crypt 
hyperplasia, increased permeability, and inflammatory cell filtrate. The mechanisms 
underlying environmental enteropathy are incompletely understood. Evidence suggests that 
the hyper-stimulated gut immune system results in an inflammatory, hyper-immune state 
consequently causing a disrupted gut immune response, reduced delivery, absorption, and 
utilization of nutrients, thus causing nutritional deficiency (8). Furthermore, exposure to 
bacteria through fecal-oral transmission has been suggested to induce morphological changes 
in the intestine, thus leading to increased intestinal epithelial damage, permeability, and 
microbial translocation into the lamina propria. This causes an influx of inflammatory cells to 
the intestine, eventually leading to local and systematic inflammation (9). 
Gastrointestinal illness and growth impairment 
Short-term associations between diarrhea and weight loss are well-accepted; however, long-
term associations between diarrhea and growth are less well defined (10). A framework of 
primary drivers of stunting in low-resource settings informed by population attributable 
factors suggests that among five identified child-level risk factor categories (infection, diet, 
birthweight, pollutants, environmental enteric dysfunction), infections (i.e. diarrhea, HIV, 
malaria, respiratory illness, helminths) contributed most to stunting. Furthermore, diarrhea 
was the greatest single cause of stunting, indicating that the burden of mild diarrheal disease 
remains a key contributor to sub-optimal child growth with a potential long-term effect on 
child development and adult health (11). 
The systematic review investigating diarrheal disease mortality in children <5 years of age 
reported that each day with diarrhea was associated with decreased height-for-age (LAZ), 
weight-for-age (WAZ), and weight-for-height (WHZ) z-scores (6). Pathogens causing food-




enterotoxins were excluded from the review due to the scarcity of available data with respect 
to their importance in developing countries (12). 
A secondary data analysis of 7 cohort studies from 4 countries (Bangladesh, Brazil, 
Guinea-Bissau, Peru) conducted between 1985 and 1997 showed an association between 
diarrhea and a small but measurable long-term decrease in linear growth. The study showed 
that 10 additional days of diarrhea/child/year of follow-up had a negative relationship with 
LAZ at 24 months of age (change in LAZ: −0.1, 95% CI -0.1, -0.0; P= 0.000). The cumulative 
association between the average diarrhea burden (equivalent to 23 diarrhea days/year) and 
length at age 24 months was −0.38 cm (95% CI: -0.59, -0.17). This indicates that days with 
diarrhea during individual months had little apparent relationship with linear growth. 
However, cumulative diarrhea episodes demonstrated a small but measurable association 
between diarrhea burden and linear growth. Thus, any single episode of diarrhea during 
childhood seemingly only has a small relationship with linear growth and can be recovered 
through catch-up growth, provided adequate illness-free time. However, when accumulated 
throughout the first 24 months of life, diarrhea may be associated with a loss in height 
potential (10). This ‘double burden’ of diarrhea and malnutrition may make children with 
stunted growth and repeated gut infections at increased risk of developing obesity and its 
associated comorbidities, thus representing a ‘triple burden’ of the impoverished gut The 
mechanism is not completely understood, but nutrient deprivation as well as other potential 
insults (e.g. maternal stress, inflammation) during gestation have been suggested to cause 
epigenetic changes such as DNA methylation and histone acetylation, modifying expression 
of genes related to metabolism and growth, particularly insulin growth factor-2 (IGF-2) to 
prepare the individual for potential future caloric deficiencies (reviewed in (13) with reference 
to 3 longitudinal and 2 cross-sectional studies). 
The global burden of diarrheal disease among children below 5 years of age in 188 countries 
was reviewed in the context of different diarrhea-associated sequelae. The findings suggest 
that an episode of diarrhea can lead to a potential pathogen-specific diversity loss in gut 
microbial communities. Poor composition of the microbiota may contribute to 
malnourishment, reduced response to oral vaccines, increased susceptibility to additional 




Another review suggests a strong association between stunting and early-childhood diarrhea 
in general, and with Cryptosporidium, Entamoeba histolytica, and Shigella infection in 
particular. Apart from macronutrient malabsorption resulting from environmental 
enteropathy or other pathways, children may experience appetite suppression and may be 
fed lower than usual amounts. In addition, systemic or intestinal inflammation due to 
bacterial translocation can negatively regulate insulin-like growth factor 1 (IGF-1; lower levels 
of IGF-1 have been suggested to mediate stunting in early life due to IGF-1’s function at 
growth plates (14)), thus inhibiting growth (15). 
Environmental enteropathy, rather than diarrhea, has been proposed as primary causal 
mechanism between poor water, sanitation, and hygiene practices and stunting. Pathways by 
which enteropathogenic infections may lead to chronic health consequences are complex and 
not fully understood. Intestinal inflammation as a result of infection with enteropathogenesis 
and distortion of the intestinal barrier and absorptive function have been suggested to imply 
changes in the host microbiome. While malabsorption itself can contribute to growth 
faltering, changes in the microbiome may lead to autoimmune dysfunction (15).  
As described above intestinal morphological and subsequent intestinal epithelial damage, 
permeability, and microbial translocation resulting from environmental enteropathy cause an 
influx of inflammatory cells eventually leading to local and systematic inflammation. 
Resources that would be normally directed toward child growth and development are 
reallocated and hormonal pathways that regulate growth plate activity in long bones are 
disrupted. Chronic inflammation and reduced intestinal nutrient absorption are also 
hypothesized to affect brain development, inducing lasting negative effects on cognition, 
educational achievement, and linear growth (9). The above-described nutritional deficiency 
impairs the renewal of epithelial tissue as well as the maturation and proliferation of intestinal 
and pancreatic ß-cells resulting in linear growth faltering. In addition, the low-grade 
inflammatory state concurrently impedes bone growth, and consequently height, by 
inhibiting endochondral ossification (8). 
A systematic review from 2018 assessed the relationships among five environmental enteric 
dysfunction domains (i.e. intestinal damage and repair, permeability and absorption, 




domain and stunting. The review questions a direct relationship between intestinal 
permeability (i.e. small pores between epithelial cells allowing for paracellular permeation of 
e.g. lactulose) and microbial translocation (i.e. passage of microbes/microbial products 
through the epithelial barrier into the lamina propria and local mesenteric lymph nodes) and 
between microbial translocation and stunting. Rather, the authors suggest inconsistent and 
variable relationships between environmental enteric dysfunction domains, while strong 
evidence supports the relationship between intestinal inflammation and systemic 
inflammation as well as between intestinal inflammation and stunting (9). A recent study in 
Tanzanian children further reported a significant association between systemic inflammation 
at six weeks of age and stunting (HR 2.14, 95% CI: 1.23, 3.72; p = 0.002) (16). 
Factors other than microbial translocation, such as pathogen colonization with subsequent 
changes in the intestinal microbiota, may be responsible for intestinal inflammation in 
individuals with environmental enteric dysfunction. The authors speculate that 
environmental enteric dysfunction is not a single entity, but rather a set of phenotypes 
dependent on unique environmental exposures with geographic variations. Small intestinal 
bacterial overgrowth may also contribute to intestinal inflammation and environmental 
enteric dysfunction; however, evidence for a relationship between stunting and small 
intestinal bacterial overgrowth is lacking (9). 
Mycotoxin exposure has been associated with environmental enteropathy. Three biologically 
plausible pathways through which aflatoxin exposure may affect growth have been 
suggested. These include 1) zinc deficiency, 2) inhibition of protein synthesis resulting in 
impaired metabolism, as well as 3) enterocyte damage ultimately leading to systemic immune 
activation. Similarly, suggested causal pathways for fumonisin exposure include decreased 
food intake and an inhibited sphingolipid metabolism, which may cause a degradation of 
epithelial barrier and stimulation of an inflammatory immune response. Human evidence for 
pathological effects of other mycotoxins such as deoxynivalenol and zearalenone is scarce, 
however, rodent studies indicate a negative effect of deoxynivalenol on growth due to 





3.1.2. Impact of foodborne disease on nutrient absorption 
The morbidity impact of enteric pathogens is to a large extent due to their ability to directly 
impair intestinal nutrient absorption (18). Efficient digestion of food constituents depends on 
various, interconnected processes (e.g. secretion of intraluminal enzymes and bile salts; 
regulation of intraluminal pH, transit of intestinal contents), pathogens may alter each of 
these processes by causing hypochlorhydria, by physically blocking pancreatic or biliary ducts, 
by damaging the mucosal surfaces, or by hastening peristaltic propulsion (19). Several 
foodborne pathogens may impact the absorption of different nutrients; however, evidence 
seems strongest for the effect of helminths and Helicobacter pylori. 
The detrimental impact of helminth infections on nutrient status has been attributed to 
intestinal inflammation and obstruction, appetite loss, as well as blood loss due to internal 
bleeding. Negative associations between helminth infection and serum retinol (used to 
determine vitamin A deficiency in populations (20), but not serum ferritin (used to determine 
iron status in individuals and populations (21) were identified, however, deworming led to a 
rise in hemoglobin (used for the diagnosis and classification of anemia (22)) (23-26). 
An impact of Helicobacter pylori on nutrient status has been suggested through changes in 
gastric physiology and histology, as well as impaired nutrient uptake. Evidence from 
systematic literature reviews indicates Helicobacter pylori associated increases in iron 
deficiency, anemia, and iron deficiency anemia. Furthermore, an association with lower 
cobalamin and folate levels as well as lower levels of ascorbic acid in plasma and gastric juice 
have been reported. In addition, Helicobacter pylori eradication had a positive effect on 
ascorbic acid in gastric juice and serum cobalamin (27-30). 
3.1.3. Impact of foodborne disease on perinatal/reproductive health 
Foodborne disease may impact perinatal health outcomes (e.g. gestational diabetes, fetal 
development, via different mechanisms (e.g. changes in glucose metabolism, dehydration; 
Table 1. In addition to impacts on the health and nutritional status of the pregnant woman, 





Helicobacter pylori affects perinatal outcomes through suggested effects on glucose 
metabolism and endothelial damage. Meta-analyses showed significant associations between 
Helicobacter pylori infection and antenatal hyperemesis gravidarum (38 studies), fetal growth 
restriction (16 studies), gestational diabetes (reports from 3697 cases), as well as low birth 
weight (8 studies) (31, 32). 
Meta-analyses showed associations between Vibrio cholerae and fetal (4 studies), neonatal, 
and maternal death (9 studies each). Suggested mechanisms include maternal and fetal 
acidosis as well as electrolyte changes in the amniotic fluid resulting from severe vomiting 
(33, 34). Toxoplasma gondii and Listeria monocytogenes are two key bacterial pathogens 
associated with adverse reproductive outcomes. Toxoplasma, which can be transmitted 
vertically from expectant mother to fetus, may result in severe negative outcomes on fetal 
development, ranging from fetal growth restriction (FGR), preterm birth, fetal anomalies, and 
congenital toxoplasmosis (frequently resulting into ocular lesions, mental and growth 
retardation, and other issues related to nerve development) to fetal death (35, 36). Listeria 
monocytogenes also has a higher prevalence, higher severity during pregnancy, in addition to 
a high rate of fetal deaths, preterm births, and fetal distress (37). While direct mortality 
outcomes are outside the scope of this review (i.e. for this review death from a foodborne 
illness is considered a direct outcome of the illness, not mediated by nutrition factors, and 
hence excluded from the discussion on links between food safety and nutrition), they should 
be kept in mind as the extreme boundary of both foodborne hazard and nutrition impacts. 
A systematic review published in 2020 suggests an association between mycotoxin exposure 
and intrauterine fetal growth restriction, whereas evidence regarding perinatal death, 
preterm birth and decreased birthweight is inconclusive (38). 
Arsenic exposure is also thought to affect perinatal outcomes, namely low birth weight, 
preterm delivery, birth weight decline, as well as decreased birth size. The available evidence 
is minimal and mostly relies on cross-sectional studies. Inorganic arsenic can accumulate in 
the placenta where it may disrupt and alter cord blood methylation, in addition, arsenic can 
also cross the placenta and accumulate in developing fetal organs However, no meta-analysis 
was conducted as reviewed studies examined different mycotoxins and outcomes with 




3.1.4. Foodborne diseases with impact on metabolic processes 
Glucose metabolism 
Foodborne disease can impact glucose metabolism through altering the host’s receptors 
and/or autoimmune response. A review of 7 case-control studies suggests chronic 
toxoplasmosis as possible risk factor for type 2 diabetes mellitus, while there is no significant 
association with type 1 diabetes mellitus. Suggested mechanisms include auto-immune and 
inflammatory processes in addition to a direct invasion, destruction of pancreatic b-cells, 
intracellular pathogen stimulation, as well as impaired phagocytosis and increased 
susceptibility to opportunistic infections (42). Phthalates may promote type 2 diabetes 
through receptor alteration and induction of oxidative stress; however, evidence is limited. 
The single prospective study that examined incident diabetes as an outcome reported strong 




Most animal studies show anti-thyroid effects upon high nitrate/nitrite exposure; however, 
this has so far not been confirmed in humans. Nitrites and nitrates can inhibit iodine uptake 
which may subsequently lead to decreased thyroid hormone production. Chronic thyroid 
gland stimulation may induce a change of follicular cells and hypertrophy or hyperplasia. 
A meta-analysis showed no significant association between nitrate exposure and the risk of 
thyroid cancer, hyper- and hypothyroidism. However, three cohort studies showed a 
significant association between higher exposure to nitrite and the risk of thyroid cancer (risk 
= 1.48, 95% CI = 1.09–2.02, P = 0.012) (44). 
Obesity 
Exposure to persistent organic pollutants (POPs), polychlorinated biphenyls, and bisphenol A 
has been associated with obesity due to impaired thermogenesis and increased adipocyte cell 




from in vivo studies, for polychlorinated biphenyl (PCB) and bisphenol A evidence is available 
from observational studies (45, 46). 
Cancer outcomes 
Foodborne pathogens are associated with different forms of ulcerative disease or cancer at 
various body sites (e.g. skin, lung, liver). This review focuses on ulcers/cancers directly 
impacting the gastrointestinal tract. Meta-analyses of 46 studies from 24 countries indicated 
a 1.26-fold risk for peptic ulcer for Helicobacter pylori infection. Furthermore, Helicobacter 
pylori eradication was significantly associated with decreased risk of gastric cancer. It has 
been suggested that chronic gastric inflammation may lead to precancerous changes of 
atrophic gastritis and intestinal metaplasia, whereas chronic infection may cause 
hypochlorhydria (47-49). 
3.1.5. Impacts of foodborne disease treatment on nutritional outcomes 
 
In this section we briefly highlight examples of treatments of foodborne disease in respect to 
their potential impact on nutrition outcomes. As this assessment was not the primary 
objective of our review it is not meant to be exhaustive, but rather aims to complement other 
sections of this review. Seemingly, the evidence linking a specific treatment to adverse 
nutrition outcomes is scarce. A more targeted systematic review may allow for elucidating 
this issue further and can provide a broader context to inform future research efforts. 
Evidence for this section was compiled from three systematic reviews, two reviews (non-
systematic), and one cohort study. 
Treatment of infectious enteric disease with antimicrobials 
Antibiotic treatment of infectious enteric disease may yield profound effects on the 
composition and function of the gastrointestinal microbiome. Specific classes of agents (e.g. 
β-lactams, fluoroquinolones) predispose subsets of individuals to antibiotic-associated 
diarrhea and colitis due to specific pathogens. Antimicrobial-associated disorders result from 
the short- and long-term impacts of antibiotics on the composition and function of the human 
microbiome. Perturbations of the gastrointestinal microbiota create opportunities for 




result in symptomatic diarrheal illness. The primary etiologic agent of antimicrobial-
associated diarrhea, toxigenic Clostridium difficile, accounts for an estimated 15%–25% of 
cases. Other agents that have been associated with antimicrobial associated diarrhea include 
clostridial etiologies (including enterotoxin-producing strains of Clostridium perfringens and 
possibly Clostridium spiroforme) as well as enterotoxin-producing strains of Staphylococcus 
aureus (50). Interestingly, a meta-analysis of ten randomized controlled trials indicates that 
antibiotic use increased height and weight, with larger effects on height in younger 
populations. This antibiotic growth promoting effect may be mediated by treatment of clinical 
or subclinical infections or by modulation of intestinal microbiota (51, 52). 
Deworming 
Deworming via preventive chemotherapy is carried out to lower the burden of helminth 
infections and improve development outcomes (e.g. height and weight gain) (53). A Cochrane 
systematic review of 52 studies carried out in 2017 and assessing the effects of mass 
deworming on health outcomes found little evidence of adverse events from deworming, 
including impacts on nutrition outcomes (54). The review found that mass deworming for soil-
transmitted helminths with albendazole twice/year compared to controls had little to no 
improvement in weight or height over a period of about 12 months (0·09 kg, 95% credible 
intervals [CrI] -0·04, 0·20 and 0·07 cm, 95% CrI -0·10, 0·24, respectively; moderate certainty 
evidence), little to no difference in weight-for-height (0·14, 95% CrI -0·20, 0·47; high certainty 
evidence), proportion stunted (eight fewer per 1000 children, 95% CrI -48, 32; high certainty 
evidence), or mortality (one fewer per 1000 children, 95% CI -3, 1; high certainty evidence). 
Administration of albendazole led to minimal adverse events (moderate certainty evidence) 
and no studies reported cases of intestinal obstruction. Of the included studies, 2 studies 
reported that effects of deworming were not sustained once deworming was ceased 
(moderate certainty evidence) (54). 
Antiamebic treatment 
Another Cochrane systematic review from 2019 investigated the effects of antiamebic drugs 
for treating colitis. Of the 41 included trials, 37 reported predominantly gastrointestinal 




discomfort. The authors conclude that, compared with metronidazole, tinidazole may be 
associated with fewer adverse events (moderate-certainty evidence) while also being more 
effective in reducing clinical failure (low-certainty evidence) (55). Similar findings were 
reported by a systematic review conducted in 2007 that assessed adverse effects of drug 
treatments for amebic dysentery in endemic areas. The study found that ornidazole may be 
more effective at curing amebic dysentery compared to placebo but that this treatment may 
cause nausea and vomiting. Furthermore, it was unclear whether tinidazole performed better 
than placebo, but tinidazole outperformed metronidazole with fewer adverse effects (very 
low-quality evidence) (56). Such side effects may detrimentally affect nutrient status due to 
reduced food consumption as well as impaired nutrient absorption and possible disruptions 
of physiological gastrointestinal mechanisms. 
 
3.1.6. Foodborne disease and nutrition outcomes in vulnerable populations  
 
Foodborne pathogens may take advantage of weakened immune systems, putting vulnerable 
populations such as infants and young children, pregnant women, the elderly, and immuno-
compromised individuals at particular risk of contracting common food-related diseases (5). 
In addition, infants and pregnant women often have different consumption patterns and 
nutrient requirements compared to other family members, potentially affecting their 
exposure to certain food-associated hazards (57). In this section, we compiled evidence from 
ten reviews (two systematic, eight non-systematic) and one orginal research article. While it 
seems intuitive that foodborne disease affects nutrition outcomes in vulnerable populations, 
surprisingly little evidence in this area is available. Specifically, it is unknown whether and to 
what extent vulnerable populations (compared to non-vulnerable ones) are more susceptible 
to short- and long-term adverse etiologies of nutritional outcomes linked to fodborne 
diseases.  
Populations affected by malnutrition 
Low weight, particularly weight-for-height, is a serious risk factor for infectious diseases, with 
possible immediate, acute negative effects on systematic and mucosal immune system 
functions (13). A systematic review on immune function in children with malnutrition that 




reduced exocrine secretion of protective substances, and low levels of plasma complement. 
The authors suggest that immunological alterations associated with malnutrition in children 
may contribute to increased mortality; however, the underlying mechanisms are not 
completely understood (58). 
Several studies suggest that malnourished individuals are particularly susceptible to 
detrimental arsenic-related health effects (with arsenic exposure being primarily via food 
ingestion). In utero and/or early-life arsenic exposure has been linked to increased mortality 
due to multiple cancers, lung disease, heart attacks, and kidney failure as well as detrimental 
effects on cognitive development, intelligence, and memory later in life (41). 
Undernutrition is both a sequela of, and a risk factor for, cryptosporidiosis, particularly in 
children (59). A triple-cohort study in Haitian children <18 months of age (children with 
cryptosporidium and diarrhea, diarrhea only controls, healthy controls) demonstrated that 
children with acute cryptosporidiosis were more malnourished compared to both control 
groups and also had elevated markers of proinflammatory immune response [e.g. tumor 
necrose factor αRI (TNF-αRI) was elevated in 21 of 28 case patients (P=.004) to a maximum of 
4809.7 pg/mL; furthermore, among cases with detectable fecal lactoferrin, all TNF-αRI levels 
were >200 pg/mL (range, 220–3559 pg/mL)] (60). The Cryptosporidium burden was highest 
in children <1 year amounting to nearly 250 DALYs per 1000 child-years in sub-Saharan Africa 
in this age group with most of this burden attributable to long-term outcomes associated with 
undernutrition (59). 
Children 
Children <5 years of age carry a large proportion (40%) of the disease burden attributable to 
foodborne hazards, despite representing only 9% of the global population (5). Malnourished 
infants and children are at higher risk of developing serious forms of foodborne diarrheal 
diseases, which can exacerbate malnutrition, thus leading to a vicious circle of debilitation 
and mortality and preventing many from reaching their full potential in society (5). Children 
are also more vulnerable to the consequences of infection because of their developing 
immune system, small body size, lower levels of gastric acid and other factors (57). In addition, 




over food preparation and may exhibit behaviors that can increase risk (e.g. eating soil or 
animal feces) (61). 
Gender 
Gender can be an important determinant of exposure of risk, often as a proxy of other 
underlying drivers. For instance, gender is often correlated with poverty and poverty in turn 
is associated with increased burden of both foodborne disease and malnutrition (62). Gender 
roles and occupations can also drive health outcomes. A recent assessment of 20 informal 
livestock and fish value chains found socially constructed gender differences as major driver 
of differences in health risks. With the exception of one study on listeriosis risk, differences 
in risk of foodborne disease were attributable to gender roles and occupation rather than 
biological sex. While men were most likely to suffer from occupational exposure and injuries 
associated with livestock production, fishing, hunting, and slaughterhouse work, women were 
more exposed to food-borne pathogens during processing, selling, and preparation of food 
(63). Another study argues that males may be at higher risk of exposure to occupational 
health hazards in the meat supply chain, because slaughtering is mainly performed by men 
(64). Studies on slaughterhouse workers have indeed highlighted deficiencies in food safety 
practices (64). Additional example of increased exposure to foodborne or zoonotic pathogens 
include vendors and workers in informal markets, who are in more frequent and close contact 
with food and food-contact surfaces (65). Increased impacts on nutrition outcomes could be 
inferred – albeit not yet well supported by data – as a consequence of increased foodborne 
or occupational exposure. In addition, preferential access to some foods by food producers 
may impact the composition of their diet. 
 
Only one study on listeriosis risk identified differences in foodborne disease outcomes as 
attributable to sex or biology, as susceptibility to infection by Listeria monocytogenes is 
heightened during pregnancy (63). As another example, albeit without a hazard-specific link 
to nutrition outcomes besides gastrointestinal illness, in the adult population invasive 
amebiasis is more common in males than females, particularly for amebic liver abscess, while 
no gender difference is seen in children (66). These findings suggest that gender differences 




associated with gender roles and occupation, rather than biological sex differences. However, 
further investigation is warranted. 
 
In contrast, a higher risk for developing post-infectious irritable bowel syndrome was 
associated with female gender, younger age, anxiety, long duration of diarrhea, and weight 
loss (67). Likewise, cohort studies in Bangladesh demonstrated possible sex-dependent 
associations between arsenic exposure and child growth in girls (39). Furthermore, a 
systematic review from 2011 found a gender effect for the association between exposure to 
PCB and obesity, with girls being more susceptible, whereas prenatal PCB exposure was 
associated with reduced birth weight predominantly among male infants (68). 
Other vulnerable populations 
Pregnancy, old age, and immune status can also result in increased vulnerability to foodborne 
hazards, and associated nutrition outcomes. For example, limited evidence based on 
epidemiological data suggests that listeriosis is more prevalent in pregnancy than in non-
pregnant populations, with 16–27% of all Listeria monocytogenes infections occurring in 
pregnant women, which result in a high rate of fetal distress and miscarriage (37, 69). 
Nutrition outcomes associated with Listeria infection are described in Table 3. Likewise, old 
age as well as medical interventions that severely compromise the immune system greatly 
increase the susceptibility to acquiring listeriosis (70). While non-invasive forms of listeriosis 
cause symptoms such as diarrhea, fever, headache, and myalgia, listeriosis during pregnancy 
can cause prenatal fever, meconium-stained amniotic fluid, fetal distress, or even death (37). 
The host’s innate and adaptive immunity also play a major in the severity of prognosis for 
cryptosporidiosis and giardiasis. Immunocompetent individuals typically experience self-
limiting diarrhea and transient gastroenteritis and recover without treatment, suggesting 
efficient immune responses, whereas immunocompromised individuals including HIV/AIDS 








In this review we summarized evidence on the linkages between food safety and nutrition by 
discussing key physiological effects of unsafe food, with a focus on health-related impact 
pathway linking foodborne diseases to nutrition outcomes. The risks associated with unsafe 
food consumption are undoubtedly substantial yet are not systematically quantified. 
Estimates attribute about one third of global diarrhea cases to foodborne disease. However, 
reliable data are lacking for several countries and regions. This uncertainty, as well as limited 
data to attribute disease burden to specific foodborne hazards or food categories limits the 
ability for an adequate response (71).  
Foodborne disease burden is increasing in LMICs owing to increases in the consumption of 
animal-source foods, rapid lengthening and increasing complexity of value chains, as well as 
slow/missing improvements in food safety governance, among other factors (72). These 
impacts may not be felt equally across society. While cross-impacts between food safety and 
nutrition may be non-linear, arguably an increase in foodborne disease burden would also 
result in an increase in associated negative nutrition outcomes. We identified strong linkages 
between some foodborne hazards and nutrition-related outcomes; however, several gaps 
and limitations in the reviewed literature (discussed below) impair our full understanding and 
our ability to establish causality.  
4.1 Physiological and public health implications 
We consider the available evidence with regards to a relationship between pediatric 
gastrointestinal illness and growth impairment as strong. However, the extent of this 
relationship and underlying mechanisms are not completely understood. Furthermore, the 
exact determinants of gastrointestinal illness that may cause impaired growth as well as the 
impact of timepoint and duration of illness are still debated. Also, no clear evidence of an 
association between adult gastrointestinal illness and malnutrition emerged from the 
literature reviewed. Evidence also points toward a negative impact of certain hazards on 
nutrient absorption (e.g. helminths, Helicobacter pylori), growth outcomes (e.g. mycotoxins, 
arsenic), metabolic functions such as glucose and thyroid metabolism (e.g. persistent organic 
pollutants and other chemicals), as well as gastrointestinal ulcers (Helicobacter pylori). For 




because they have been investigated for decades, while research for other hazards is still in 
its infancy.  
Studies investigating the relationship between pathogens and diarrheal disease present 
inherent limitations. Certain organisms may remain in the feces for a long time after an 
infection-causing illness, possibly leading to misclassification as a non-diarrhea causing agent. 
Similarly, longitudinal studies may identify long-term secretors after illness from 
asymptomatic infections (6). The systematic review investigating specific pathogens that may 
be associated with persistent diarrhea in children in LMICs found no evident association 
between a particular pathogen and persistent diarrhea (73). The review showed that both 
children with persistent diarrhea and without diarrhea carried a wide range of enteric 
pathogens with varying rates between studies. The authors highlight methodological 
limitations in the reviewed studies including varying designs, small sample sizes, and the 
assessment of different (combinations of) pathogens. Furthermore, the use of different 
classification systems in some cases prevented a combined analysis of data across studies 
(73). Other studies have identified additional gaps pertaining to methodological issues. 
Common gaps found in the studies include (1) lack of controlling for confounders such as e.g. 
previous health history, (2) duration of illness, (3) nutrient intake/status, seasonality, (4) 
exposure dose and duration as well as (5) exposure to other potential hazards. Furthermore, 
cross-sectional study designs, lack of representativeness of study populations, as well as small 
sample sizes have been recognized (29, 44, 47).  
The review revealed other methodological limitations that, if addressed, could improve the 
evidence base on foodborne diseases’ impacts on nutrition outcomes. In terms of burden 
assessment, for example, many foodborne hazards lack well-established biomarkers and/or 
cheap, readily available tools for their identification, which hinders exposure assessment and 
attribution, which are in turn needed for effective interventions. Furthermore, evidence from 
well-designed human studies is often lacking along with consistent clinical definitions (e.g. 
environmental enteropathy) and improved education of healthcare professionals regarding 
foodborne disease symptoms (9, 74, 75). Study findings may also be biased towards certain 




While different aspects of food safety research have well-developed metrics, in many cases 
available metrics are not widely applied or not suited for widespread use (72). There are also 
no established approaches for assessing the proportion of adverse nutrition outcomes, such 
as wasting or stunting, associated with foodborne infections. Another challenge is the lack of 
specificity for some symptoms which may not allow for an accurate diagnosis, in addition to 
individuals not seeking healthcare. Both may lead to under-reporting and subsequent under-
estimation of health-impacts in response to certain hazards. Many countries also lack 
adequate public surveillance systems to track foodborne disease. The resulting dearth of 
epidemiological data hinders the quantification of the full extent and cost of foodborne 
disease. In turn this prevents policy-makers from setting priorities and allocating resources 
towards improving food safety and associated nutrition outcomes (5). This is even more true 
for assessing impacts of foodborne disease on nutrition, for which data and evidence are 
largely lacking and are not accounted for in surveillance systems.  
Other health implications, while not covered in depth in this review, warrant further 
attention. Pharmacological treatment of infectious foodborne disease may lead to short-term 
nutrition impacts, but evidence suggests this impact is minor. However, antimicrobial 
treatments can alter the intestinal microbiome in the short- and long-term, with poorly 
understood impacts on gut health. Holistic investigation of medium- to long-term impacts of 
certain foodborne disease treatments on health and nutrition outcomes, as well as 
socioeconomic outcomes are warranted. Also, there is limited available evidence regarding 
vulnerable populations and population-specific exposure and foodborne disease outcomes, 
as well as their implication for nutrition outcomes. Particularly, the role of sex and gender as 
determinants are not well understood or quantified.  
4.2 Limitations and suggestions for future research 
We aimed to provide a broad picture of the impacts of foodborne hazards and disease on 
nutrition-relevant outcomes, with a focus on low-resource settings. Given the high complexity 
of this topic, it was not possible to capture all impacts within a parent search strategy. Rather, 
we aimed to provide an overview of relevant issues and highlight evidence gaps to inform 
future research efforts. For instance other relevant health implications, such as impacts of 




abilities to work or care for a family, are relevant in the context of overall health and nutrition 
outcomes but were outside of the scope of this review. In addition, the review focused on the 
impacts of food safety on nutrition outcomes, not vice versa. Lastly, strength of evidence was 
discussed throughout the review, but could not be quantified. 
In the process of reviewing the existing literature on food safety impacts on nutrition 
outcomes, we also identified several gaps that could be filled by future research efforts: 
• Harmonized metrics and rigorous research methods should be developed and applied 
across the disciplines of nutrition and food safety.  
• Longitudinal studies are needed to assess temporal relationships and long-term 
impacts of foodborne disease on nutrition outcomes. Such studies should address sex-
/gender-related aspects that may confound research findings.  
• Inexpensive, readily accessible, and decentralized tools should be developed for 
reporting on relevant metrics to facilitate foodborne illness attribution to specific 
hazards and routes of transmission.  
• The study of physio-pathological mechanisms of foodborne disease – including long-
term health impacts – and their links to specific hazards should be strengthened and 
made more quantitative.  
• Nutrition outcomes should be better accounted into the burden of foodborne 
diseases. However, data and methods do not currently allow for a satisfactory 
inclusion of these variables. 
 While a comprehensive review of socioeconomic processes linking food safety and nutrition 
was outside the scope of this review, the literature search also highlighted the dearth of 
evidence on the dietary and socioeconomic impacts of food safety and foodborne disease, on 







5. CONCLUSIONS AND IMPLICATIONS FOR EATSAFE 
PROGRAM DESIGN 
 
This review documents linkages between food safety and nutrition.  While in some cases the 
main mechanisms involved are known, these complex networks of causal physiological 
pathways are often difficult to disentangle. In general, there is more evidence regarding the 
impact of foodborne diseases on health and nutrition-relevant outcomes, than on the 
opposite direction of impact, i.e. impacts of malnutrition on vulnerability to or severity of 
foodborne disease. 
Some foodborne hazards have been found to be associated with nutrition and development 
outcomes. However, assessing the impact of these impacts at population scale requires 
additional efforts in terms of data collection and harmonization of analytical approaches 
across disciplines. Other factors, such as gender differences, vulnerable groups, and the 
availability and impact of treatments also warrant further attention by researchers and risk 
managers. 
 
Key summary findings and considerations relevant to intervention design, within and beyond 





Recommendations for Intervention Design and Future Studies under EatSafe 
  
This review provides an overview of cross-pathways linking food safety/foodborne illness and nutrition 
outcomes with focus on health impacts. This body of evidence is meant to support the development of a 
framework linking food safety and nutrition, as part of Feed the Future and EatSafe programming.  
Key findings and considerations include: 
• Food safety and nutrition are strongly linked via many impact pathways, in some cases through direct 
association (e.g. environmental enteropathy is linked to stunting), while in others food safety and 
nutrition processes may both impact a health outcome (e.g. diabetes or other metabolic processes). 
• There is strong evidence that some forms of gastroenteric disease are associated with nutrition 
outcomes, such as stunting, in children below 5 years old; however, the specific causal mechanisms 
are still under study. Little evidence is available on adults. 
• Since diarrhea and environmental enteropathy are linked to nutrition outcomes in LMICs, but appear 
to be associated with multiple pathogens, at this stage of data availability interventions aiming to 
control both FBD burden and associated nutrition impacts may benefit from a broad focus involving 
multiple pathogens, instead of a more limited focus on few pathogens or pathogen/commodity pairs. 
However, pathogen-specific studies are needed to understand exposure and attribute burden. 
• Physiological mechanisms linking specific foodborne hazard to health and nutrition outcomes are not 
well characterized, in particular for chronic or time-delayed impacts. 
• The connection between a foodborne hazard and major acute health impacts is in most cases 
established, but data on burden at national and sub-national scale is lacking. 
• People purchasing food from informal markets might be more at risk for the cumulative impacts of 
foodborne disease and associated nutrition impact, including from WASH and housing exposures. 
• The incidence and magnitude of impacts linking food safety and nutrition outcomes at total diet and 
population scale is poorly understood. Even if there is evidence that an impact can occur, its 
importance at population scale is often unknown.  
• The relative magnitude of impacts should be carefully considered when prioritizing interventions. 
Some well-characterized pathways may not be the most important in terms of population burden. 
• Strength of evidence for pathways linking food safety and nutrition is poorly characterized, hindering 
the ability to prioritize which factors to account for. 
• Gender factors are often not included in studies linking food safety and nutrition. Health burden data 
as well as behavior data, when available, can usually be disaggregated by gender. How other exposure 
and physiological mechanisms affect genders differently is unclear.  
• For some hazards, gendered differences in illness rates may be due to gendered occupational 
behaviors (e.g. slaughterhouse workers are usually male), not to biological differences. Messaging 
interventions customized by gender and/or occupation may we warranted. 
• Other vulnerable groups, such as pregnant women, the elderly, children, and groups at higher risk of 
occupational exposure should be considered at potentially higher risk of adverse nutrition outcomes 
associated with foodborne hazards. 
• In light of current evidence gaps, the selection of nutrition outcomes to evaluate and monitor in food 
safety programs needs further discussion. Recommended actions and outcomes for consideration 
include: measuring incidence and extent of child development outcomes; fostering increased 
syndromic surveillance and hazard attribution; including metrics of gut health (as available); including 








See document for Table 1 (page 11). 
 
Table 2. Foodborne disease with impact on intestinal health, and associated nutrition outcomes 
 
Physiological 
impact of FBD 
Key foodborne hazards, Main 
physiological mechanisms triggered by 
hazard 
Impact on nutrition-relevant 
outcomes 
Evidence strength Other impacts, limitations Ref 












Rotavirus, Norovirus, enterotoxigenic 
Escherichia coli, Vibrio cholerae, Giardia 
lamblia, Cryptosporidium parvum. 
Affect small intestine: adhere to mucosa, 
disrupt absorptive and/or enterocytic 
secretory processes without acute 
inflammation or mucosal destruction.  
Many organisms secrete enterotoxins → 
AMP/cGMP/Ca2+ concentration ↑ and 
target activation → watery diarrhea. 
Established links between diarrhea 
and nutrition outcomes (a) 
 
Meta-analysis of 12 





Lack of attribution 
of diarrhoea cause 
to a specific 
pathogen; true 
prevalence for 
E. coli: Post-inflammatory 
irritable bowel disease (PI-
IBS) after infection, pooled 
prevalence (95%CI): 12% 
(5–20), 4 prospective 
studies (1 only exposed 
subjects).  
Cryptosporidium: Hazard 
ratio in 12-23 months-olds: 
2.3 (95% CI 1.3-4.3); 
prospective cohort study in 










Giardia: Paradox association with 
protection from acute pediatric diarrhea, 
yet ↑ risk of persistent diarrhea. 








Shigella spp., Salmonella spp. 
Invade intestinal epithelial cells (Shigella), 
ileum or colon (Salmonella) through 
chromosomal/plasmic-encoded virulence 
factors → cell death → apoptosis → 
release of bacteria and inflammatory 
mediators. 
Campylobacter jejuni  
Invade intestinal epithelium, spread to 
adjacent cells via host invasion receptors, 
produce nuclease which induces cell 
cycle arrest and cell damage. 
Established links between diarrhea 
and nutrition outcomes (a) 
 
N/A Salmonellosis: PI-IBS 
prevalence after infection 
12% (9–15); odds ratio 
(OR): 5.5 (95% CI 2.3–12.8); 
Meta-analysis of 3 cohort 
studies. 
Shigellosis: PI-IBS 
prevalence after infection 
11% (8–15%); OR: 13.8 
(4.2–45.4), 2 prospective 
studies, 1 study with 
exposed patients. 
Campylobacter spp.: 12% 
(10–15%), 3 prospective 
studies (only exposed), 














Acute inflammatory reaction in the 
mucosa with various degrees of mucosal 
ulceration. 
Enterohemorrhagic Escherichia coli 
(EHEC) 
1) Adheres to intestinal villi, activate 
protein kinase/release Ca2+ → 
ultrastructural changes (villi 
flattening/dissolution).  




Established links between diarrhea 









PI-IBS after infection, 
pooled prevalence (95% CI) 
for 







C. difficile  
Toxins adhere to epithelial cells → 
internalization, activate cascade → 
disrupt protein synthesis, cell death, 
inflammation. 
    
Enteroaggregative/Enteropathogenic 
Escherichia coli (EAEC/EPEC) 
Adhere to intestinal brush border: 
1) Mucus (biofilm) production  
2) Acute inflammatory response: 
cytokine production, intestinal secretion  







Listeria monocytogenes  
Can resist low pH in stomach, elevated 
osmolarity, and bile salts. Pathogenesis 
incompletely understood.  
Non-invasive (febrile): diarrhea, fever, 
headache, myalgia. 
Tropisms may differ between strains. 
Established links between diarrhea 
and nutrition outcomes (a) 
N/A Invasive: penetration of the 
GI tract, phagocytosis→ 
internalization→ infections 
in normally sterile body 
sites→ replication, 
intestinal translocation.  




Impact of foodborne disease on environmental enteropathy 
Quantitative/ 
qualitative 
changes in gut 
function 
Enteroaggregative Escherichia coli, 
Campylobacter spp., Cryptosporidium 
parvum  
- Chronic fecal exposure → qualitative 
gut microbiota changes; unclear how 
enteric pathogens trigger the 
development of environmental enteric 
dysfunction. 
- Bacterial overgrowth of small intestine, 
subclinical bacterial colonization in the 
upper GI tract 
Asymptomatic Enteroaggregative E. 
coli infections → intestinal 
inflammation → linear growth ↓. 
Weak associations of 
enteroaggregative E. coli with 
biomarkers of intestinal 
inflammation.  
1 study in 8 low-
resource settings 
- Lack of surveillance and 
clinical case definitions; 
shift in biomarker 





Campylobacter spp. → markers of 
permeability ↑, intestinal and 
systemic inflammation → linear and 
ponderal growth faltering.  






- Concurrent low-grade inflammation: 
inhibition of endochondral ossification → 
inhibition of bone growth. 
- Potentially reversible villous atrophy, 
crypt hyperplasia, inflammation, reduced 
intestinal barrier function. 
Cryptosporidium parvum excretion 
associated with growth faltering; 
unclear mechanism. 






- Damage to intestinal tract  
o altered villi: crypt ratio, intestinal 
absorptive capacity ↓ → zinc deficiency 
→ protein and sphingolipid synthesis Ø; 
o enterocyte damage → systemic immune 
activation. 
- Intestinal barrier function Ø. 
- Food intake ↓. 
Higher levels of maternal aflatoxin 
exposure: height-for-age (HAZ) and 
weight-for age z-scores (WAZ) ↓. 
1 longitudinal study Most evidence from 
aflatoxin, fumonisin 
exposure; little evidence 
for deoxynivalenol and 
zearalenone, lack of 
biomarkers. 
(17) 
Pediatric fumonisin intake > 
provisional maximum tolerable daily 
intake: height and weight ↓. 
1 longitudinal study  
Inflammatory 




Cryptosporidium, Giardia lamblia  
Invasive Cryptosporidium infection: 
inflammatory damage to the small 
intestine → rapid fluid loss/inability to 
Impaired child development, 
associated with abdominal 
distension, vomiting, fever and 
weight loss mostly in children and 
individuals with HIV/AIDS.  
Various studies in 
LMICs. 
Children with poor growth 








damage to the 
small intestine 
(cont’d) 
absorb micronutrients → growth 
faltering. 
Inability to absorb macro-/micro-
nutrients during a diarrhoeal episode → 
disruption of weight and height gain as 
well as child development. 
Chronic Giardia infection → weight 
loss/malabsorption, association with 
stunting, wasting, and cognitive 
decline in children in LMICs.  
1 study in 8 low-




Each diarrhoea episode fom 
Cryptosporidium infection: 
associated with ↓ HAZ (0·049; 
0·014–0·080),  
WAZ (0·095, 0·055–0·134), and 
weight-for- height Z score (WHZ) 
(0·126, 0·057–0·194).  




- Cryptosporidium infection: 
significant association with ↓ HAZ 
(0·030; 0·014–0·045). 
Meta-analysis of 6 
studies. 
 







Helicobacter pylori  
- Change gastric physiology/histology 
o Iron: limited intestinal absorption 
(gastric ascorbic acid ↓, gastric juice pH 
↑); 
Helicobacter pylori-infected 
individuals have ↑ likelihood of, 
pooled OR (95% CI):  
 Elevated risk of: 
- Chronic cholecystitis and 
cholelithiasis, gestational 
diabetes mellitus, gastric 

















o Cobalamin malabsorption via: (1) 
Compromised release of protein-bound 
dietary cobalamin in the stomach or (2) 
Gastric atrophy of the corporal mucosa 
and intrinsic factor deficiency (pernicious 
anemia). 
- Virulence factors:  Helicobacter pylori 
CagA strains alter host’s iron stores; Iron 
uptake by H. pylori may lead to iron 
deficiency in host 
 
- Chronic occult GI blood loss 
(microbleedings). 
 
Risk factors: Low body iron stores, iron 
deficiency (anemia). 
  
- Hepatic or 
gastrointestinal illness (e.g. 
carcinoma/ ulcer, chronic 
hepatitis C, etc.); 
neurologic conditions (e.g. 
Parkinson’s disease): low 
evidence. 
- Methodological 
inconsistencies and lack of 
confounder control in 
some studies 
- Metabolic syndrome, type 
2 diabetes mellitus - very 
low evidence. 
- Anemia: 1.15 (1.00–1.32). 23 studies  
Following Helicobacter pylori 
eradication + iron therapy vs. iron 
therapy alone  
- Ferritin ↑ but not hemoglobin: 
standardized mean difference (SMD, 
95% CI): 0.53 (0.21–0.85) vs. 0.36 
(−0.07–0.78). 





- Significant association with: [total 
random effects of SMD (95% CI)]: 
o Lower levels of ascorbic acid in 
plasma: 0.193, (-0.372– -0.015) and 
gastric juice: -1.087, (1.794–0.379); 
15 and 13 studies 
assessing plasma 
and gastric juice 
levels, respectively 
 
o Cobalamin: 0.744, (-1.14– -0.340); 14 studies  
- Association with lower folate 
levels: -0.433 (-0.943, -0.078), not 
significant. 
9 studies  
- Positive effect of eradication 
treatment on ascorbic acid in gastric 
juice, -1.408 (-2.471, -0.346) and 















- Intestinal inflammation and obstruction 
→ impaired nutrient uptake, digestion, 
and absorption. 
- Abdominal pain, appetite loss 
- Internal bleeding → loss of iron → 
anemia. 
Association between helminth 
infection and serum retinol: SMD 
(95% CI) -0.30 (-0.48– -0.13); but not 
with serum ferritin: 0.00 (-0.7–0.7). 
Meta-analysis of 9 
and 7 observational 
studies, 
respectively 
Effects of mass deworming 
for: 
- Improvement in 
cognition: little-no effect; 
high certainty evidence. 






No consistent benefits of 
deworming on indicators of 
mortality, anemia, growth 
in children < 5 years or in 





(a) Clear links between diarrhea and nutrition outcomes (e.g. stunting) (85); no studies were identified which examined nutrition-related outcomes and also attributed the 
cause of acute gastrointestinal (GI) illness to a specific infectious agent. 






Table 3. Foodborne diseases with reproductive health or perinatal growth impacts 
 
Physiological 
impact of FBD 
Key foodborne hazards, Main 
physiological mechanisms triggered by 
hazard 
Impact on nutrition-relevant 
outcomes 






Helicobacter pylori  
Gestational diabetes mellitus: 
- Changes in glucose metabolism → 
chemical changes in the gastric mucosa 
- ↑ proinflammatory cytokine levels → 
structural alterations of insulin 
receptors → inhibition of insulin – 
receptor interactions 
Preeclampsia: 
- Oxidative damage → ↑ lipid 
peroxidation → endothelial damage → 
blood pressure ↑. 
- Indirect vessel damage: activation of 
clotting cascade or lymphocytes to 
produce/secrete cytokines in addition 
to proinflammatory cytokine pathway. 
Significant association between 
Helicobacter pylori infection and: 
- Hyperemesis gravidarum, 
pooled OR (95% CI): 1.348 
(1.156–1.539; P < .001); 
 
 






Inflammatory response in 
pregnant women ↑ → 
proinflammatory T-helper 17 
cells in the decidua ↑ → foetal 
stability in utero affected. 
 
Significant association between 
Helicobacter pylori infection 
and:  
- Spontaneous abortion, OR 
(95% CI): 1.50 (1.05–2.14; P = 
0.024); 
- Birth defects, OR (95% CI): 




- Fetal growth restriction: 2.28 
(1.21–4.32; P = 0.01); 
Meta-analysis of 16 
studies. 
- Gestational diabetes mellitus, 
2.03 (1.56–2.64; P < 0.001); 
Meta-analysis of 
reports from 3,697 
women. 
- Low birthweight: 1.59 (1.05–
2.40; P = 0.03). 
 
- Preeclampsia, OR (95% CI): 2.51 
(1.88–3.34; P < 0.001). 







Preeclampsia + gestational diabetes 
mellitus → fetal growth restriction. 
 Methodological inconsistencies 
among studies: varying 
Helicobacter pylori detection 





Vibrio cholerae  
- Severe maternal dehydration → 
critical hypovolemia → compromised 
placental/fetal perfusion → fetal 
hypoxia/acidosis → fetal death.  
- GI bicarbonate loss → maternal 
acidosis. 
- Severe vomiting → Electrolyte changes 
in amniotic fluid. 
Pooled rates (95% CI):  No internationally agreed 
guidelines on the treatment of 
cholera in pregnancy. 
(33, 
34) - Fetal death: 7.9% (5.3–10.4); no 
difference by trimester); 
Meta-analysis of 4 
studies. 
- Neonatal death: 0.8% (0.0–1.6); Meta-analysis of 9 
studies. 





Main suggested pathways in mother 
and fetus: 
- Pro-inflammatory cytokines ↑ and/or 
anti-inflammatory cytokines ↓. 
- Induction of enteropathy (intestinal 
inflammation, Ø placental and fetal 
development). 
- Intrauterine fetal growth Ø, 
promotion of neonatal jaundice; 
 
Some evidence 
- Fertility: aflatoxin presence 
and higher concentrations in 
semen of infertile men 
- Liver toxicity + ↑ fetal 
hemoglobin hemolysis may 
explain association with 
neonatal jaundice.  
(4, 
38) 
- Perinatal death and preterm 
birth; 
Inconclusive 
- Relationship between 
gestational aflatoxin exposure 
and birth weight ↓.  










Maternal fumonisin exposure 
potentially associated with 
hypertensive emergencies in 
pregnancy or neural tube 
defects. 
Limited number of studies, 
particularly on effects of 
fusarium mycotoxins. 
Accumulation 
in fetal organs  
Arsenic 
- Inorganic arsenic crosses the placenta 
→ accumulation in developing fetal 
organs/ systems 
- Placental accumulation → disruption 
and alteration of cord blood 
methylation. 
↑ Risk of  
- Low birth weight (<2500 grams). 
- Preterm delivery; 
Insufficient: 3 
cross-sectional 




- Cancer: Skin, liver, kidney 
bladder, urinary. 




intellectual and motor function/ 
neuropathy; 
- Coronary/ metabolic illness. 











Table 4. Foodborne disease with other nutrition-relevant impacts: cancer, metabolism, and obesity outcomes 
 
Physiological 
impact of FBD 
Key foodborne hazards, Main 
physiological mechanisms 
triggered by hazard 
Impact on nutrition-relevant 
outcomes 
Evidence strength Other impacts, limitations Ref 







Helicobacter pylori  
Peptic ulcerative disease: 
Infection → gastritis → gastric 
atrophy and intestinal 
metaplasia. 
 
Gastric cancer: Multiple 
mechanisms suggested: 
- Chronic gastric inflammation 
→ precancerous changes of 
atrophic gastritis and 
intestinal metaplasia; ↑ risk 
of gastric cancer. 
- Chronic Helicobacter pylori 
infection → ↓ gastric acid 
secretion (hypochlorhydria) → 
Infection with iceA1-positive 
Helicobacter pylori: overall 1.26-fold 
risk - for peptic ulcer (95% CI 1.09–
1.45).  
iceA1 presence significantly associated 
with peptic ulcer, OR: 1.25 (1.08–
1.44).  
iceA2 presence: inversely associated 
with peptic ulcer, OR: 0.76 (0.65–
0.89).  
iceA presence: not associated with 
gastric cancer.  
Meta-analysis of 46 







Helicobacter pylori and 
eosinophile esophagitis → 
Indirect evidence (observational 
studies) lacking direct 
experimental confirmation. 
 




Helicobacter pylori eradication → 
significantly ↓ risk of gastric cancer 








mucosal genetic instability → 
gastric microbiome growth 
promotion: processing of 
dietary components → 
carcinogens.  
Beneficial effect of eradication in 
Japan, OR: 0.39 (0.31–0.49), 
particularly among individuals with 










- Infected white blood cells: 
enhanced migratory feature 
→ facilitated spread in organs; 
autoimmune process ignition 
→ autoantibody production. 
- Improved replication in 
insulin-producing β-cells → 
activation of autoimmunity 
pathways + inflammation of 
Langerhans islets → diabetes. 
- Direct invasion/destruction 
of pancreatic β-cells → 
pancreatitis and diabetes. 
- Type 1 diabetes mellitus: common 
OR (95% CI, random effects model): 
1.10 (0.13–9.57)  
- Type 2 diabetes mellitus: 2.39 (1.20–
4.75). 
Chronic toxoplasmosis possible risk 
factor for type 2 diabetes mellitus, but 
no significant association with type 1 
diabetes mellitus.  
 
7 studies - Limitations of cases-controls 
studies; Evidence from small 
studies lacking detail; 
inconsistent methodology 
(infection definition). 
- Production of reactive oxygen 
species (ROS) and nitric oxide 
(NO) → reactivation of latent 
parasite cysts (acute infection). 
- Inability of neutrophils to 
perform phagocytosis → 










considerably subsided → 





















- Alteration of peroxisome 
proliferator-activated 
receptors which contribute to 
adipogenesis, lipid 
metabolism, and metabolic 
homeostasis; 
- Oxidative stress.  
Ø Glucose tolerance and blood 
glucose in pregnancy; 
Primary outcomes: 
number of included 
studies: 
- Type 2 diabetes: 1 
- Insulin resistance: 3 
- Impaired glucose 
tolerance and blood 
glucose in pregnancy: 
2 
- Pregnancy outcomes: 
Inconsistent evidence of 
association btw. exposure and 
time to pregnancy, preterm 
birth, spontaneous abortion, 
pregnancy complications. 
- Obesity: limited evidence (for 
low molecular weight 
phthalates) 
- Thyroid: limited evidence 
-Limited number of studies. 
Possible residual confounding 
by diet. 
(43) 
Associations with Type 2 diabetes and: 
(1) DEHP exposure. 
Moderate consistency 













positive associations in 
the diabetes study, 
coherent results for 
insulin resistance. 
(3) DINP, BBP, DEP exposure Slight evidence of no 
association in diabetes 
study for BBP and DEP. 
 
 












Nitrite/nitrate (NO2-/ NO3-) 
Inorganic NO3-, perchlorate, 
thiocyanates: I- uptake 
inhibition agents → 
competitive binding to Na+/ I- 
symporter → ↓ I- 
bioavailability, ↓ thyroidal I- 
stores, ↓ thyroid hormone 
production → ↓ thyroid 
stimulating hormone release 
from pituitary gland. 
NO3- exposure and thyroid cancer/ 
hyper-/ hypothyroidism risk  
Meta-analysis of seven 
subgroups of different 
levels of NO3- (n=4) 
and NO2- (n=3). 
A WHO report challenges 
inorganic NO3- contribution to 
endemic goiter: 
- anti-thyroid effect of NO3- 
mostly observed from drinking 
water intake, not diet; 
- NO3--induced thyroid 
dysfunction is likely weak if 
dietary iodine is available at an 
adequate range, but may be 
 
NO3-/NO2- exposure and 
hypothyroidism → OR: 0.98 (0.86, 
1.10, P=0.683) and OR: 0.98 (0.79, 
1.21, P=0.83), respectively. 
No significant 
associations (Meta-
analysis of 3 
subgroups of 2 
studies) 












Chronic thyroid gland 
stimulation → change of 
follicular cells and 
hypertrophy/hyperplasia 
induction. 
Chronic exposure to high NO3- 
levels → hypertrophy, goiter 
development. 
 P=0.012; 3 
observational studies). 
considerable in subjects with 
nutritional I- deficiency. 
Animal studies: high NO2-/NO3- 
exposure (~10–600 X acceptable 
daily intake) → anti-thyroid 
effects: ↓ thyroid hormone 
serum levels and 
histomorphological thyroid 
gland changes. No similar 
observations in humans. 









Persistent organic pollutants 
(POPs), e.g. DDT, DDE, PCB, 
phtalates. Underlying 
mechanisms sparsely studied, 
one in vivo study suggests ↓ 
in brown adipose RNA 





(p,p'-DDE): “presumed” obesogenic in 
vivo/in vitro studies. 
Moderate (humans) - Little evidence on role of 
parent compound vs. 
congeners. 
- Urinary measurements may 
not reflect long-term exposure.  
- Confounders including diet, 
use of plastic products, lifestyle 
factors.  
- In vivo/in vitro mechanistic 
studies needed. 
(45) 
p,p'-DDT exposure and - adiposity ↑. Primary in vivo 
evidence (rodents) 
Biological plausibility of obesogenic 
effects of p,p'-DDT and p,p'-DDE. 
Positive associations between p,p'0-
DDE exposure and BMI z-score: b=0:13 
Supported by 19 in 










ne (p,p'- DDT) exposure → 
energy expenditure via 
thermogenesis Ø → energy 
imbalance → obesity 
(0.01–0.25) per log increase of p,p;-
DDE.  
Dose effect for some chemicals (PCB, 
DDE, phthalates): weight gain at lower 
doses and weight loss at higher doses. 
Higher obesity susceptibility upon PCB 
exposure in girls. 
Moderate (human/in 




Bisphenol A  
Adipocyte cell differentiation 
↑ → excess fat accumulation. 
Positive correlation between the level 




Animal models show different 
obesogenic effects in males and 
females, limited human 
evidence.  
(46) 
Dose-response: 1-ng/mL BPA increase 
increased the obesity risk by 11%. 
Similar results for different types of 








Agonist/antagonist of steroid 
hormone receptors; 
Induction of specific metabolic 
pathways  
Association between prenatal PCB 
exposure and: 
 Lack of adjustment for exposure 
to other chemicals. 
(68) 
Body weight/BMI ↑ at low (<1 ng 
PCB/mg lipid) exposure; Weight ↓ at 
high (>4 ng PCB/mg lipid) exposure 
2 prospective studies 
- Pubertal girls: Body size ↑; 
- Women (20–50 years), children (3–5 
years): no association;  




- Girls (4 years): body weight ↓ 
at intermediate (≥1 – ≤4 ng PCB/mg 
lipid) exposure 
 
Ø, impaired; ↑, increased; ↓, decreased; CI, confidence interval; OR, odds ratio; LAZ, length/height-for-age z-score; WAZ, weight-for-age z-score; WHZ, weight-for height 
z-score 
(a) Phthalates considered here include: Di(2-ethylhexyl) phthalate (DEHP), Diisononyl phthalate (DINP),  Dibutyl phthalate (DBP),  Diisobutyl phthalate (DIBP), Butyl benzyl 
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Appendix I. LITERATURE OVERVIEW 
Overview of the literature included in this review. 
 
Lead Author  Year Geography Population(s) Specific food(s) Specific hazard or topic area Methods 
Abba (73) 2009 LMICs, not specified Children N/A Pathogens causing persistent 
diarrhea 
Systematic review 





N/A Nitrite/nitrate Systematic review 
Bloom (40) 2014 Bangladesh, China, India, 
Taiwan 
Pregnant women N/A Arsenic Systematic review 
Budge (8) 2019 Low- and middle-income 
countries, e.g. 
Bangladesh, The Gambia 





2017 Belgium, Denmark, 
Greece, Greenland, 
Mexico, Poland, Spain, 
Ukraine, United States 




Ciglenecki (33) 2013 Haiti Pregnant women N/A Vibrio cholerae Cross-sectional study 
Colombara (15) 2018 Global Children N/A Global disability-adjusted life-
year estimates of long-term 
health burden and 
undernutrition attributable 
to diarrhoeal diseases 
Burden assessment 
Dans (56) 2007 Not specified Children N/A Amebic dysentery Review 
Davis (84) 2019 Not specified  N/A N/A Listeria monocytogenes Review 
de Gier (26) 2014 Bangladesh, Brazil, Cote 
d'Ivoire, Egypt, India, 
Indonesia, Kenya, 
Mauretania Mexico, 
Nepal, Panama, South 
Africa, Sri Lanka, 
Vietnam, Zambia, 




N/A Helminths Systematic review 
Eng (82) 2015 Not specified  N/A N/A Salmonella Review 
European Food 
















2004 Not specified  N/A N/A Listeria monocytogenes Risk assessment 
Ford (47) 2014 China, Colombia, Japan Adults N/A Helicobacter pylori Systematic review 
Friedman (75) 2017 Not specified N/A N/A Ciguatera fish poisoning Review 
Gonzales (55) 2019 Bangladesh, Brazil, 
China, Colombia, India, 
Indonesia, Iran, Iraq, 
Mexico, Nigeria, 
Pakistan, South Africa, 
Sweden, Turkey 
Adults, children N/A Antiamebic drugs Systematic review  
Gough (51) 2017 Low- and middle-income 
countries; not specified 
Children N/A Antibiotics Systematic review 
Grace (57) 2018 N/A N/A N/A Food safety metrics in LMICs Review 
Grace (62) 2014 Several low- and middle-
income countries 
N/A N/A Food scares Review 
Grace (63) 2015 Cote d’Ivoire, Ethiopia, 
Ghana, Kenya, Mali, 
Mozambique, Nigeria, 




South Africa, Tanzania, 
Vietnam 
Grace (57) 2018 N/A N/A N/A Livestock-derived foods 
during the first 1,000 days of 
life 
Book 
Guerrant (13) 2013 N/A Children N/A Diarrhea, stunting Review 
Gulani (25) 2007 Africa, Asia; not 
specified 
Adults, children N/A Helminths Systematic review 
Harper (9) 2018 Central and South 
America, Asia, Africa; 
half of the studies were 
conducted in rural 
locations, 1 study was 
conducted in both urban 
and rural populations, 9 
studies did not specify 
the setting  
Children, adults N/A Environmental enteric 
dysfunction  
Systematic review 
Hudak (28) 2017 Argentina, Australia, 
Bangladesh, Brazil, 
Bolivia, Canada, China, 
Cuba, Denmark, Estonia, 














Tanzania, Turkey, UK, 
USA, Venezuela 
Igwaran (81) 2019 Not specified  N/A - review N/A Campylobacter spp. Review 
Jaffee (4) 2018 N/A N/A N/A overview Book 
Jones (36) 2003 N/A N/A N/A Congenital toxoplasmosis  Article 
Kim (46) 2019 China, India, Italy, Korea, 
Spain, Thailand, United 
States 
Children N/A Bisphenol A Systematic review 
Kirk (71) 2015 Global N/A N/A 22 foodborne bacterial, 
protozoal, and viral diseases 
Burden assessment 
Kirkpatrick (60) 2002 Haiti N/A N/A Cryptosporidia Cross-sectional study 
Klem (79) 2017 Multiple N/A N/A Irritable bowel syndrome 





Kotloff (78) 2013 Bangladesh, The 





severe diarrhea  
 
N/A Rotavirus, Cryptosporidium, 
enterotoxigenic Escherichia 






Kyei (38) 2020 The Gambia, Ghana, 
Kenya, Sierra Leone, 
Mexico, Nigeria, South 
Africa Uganda, United 
Arab Emirates, United 
States 
Pregnant women N/A Mycotoxins Systematic review 
Lahner (27) 2012 Not specified Adults N/A Helicobacter pylori Systematic review 
Lamont (37) 2011 Not specified Pregnancy N/A Listeria monocytogenes Systematic review 
Lanata (12) 2013 Global Children N/A Diarrhea Disease mortality 
Lee (48) 2016 China, Colombia, 
Finland, Korea, Japan, 
Taiwan 
Adults N/A Helicobacter pylori Systematic review 
Li (29) 2020 Not specified Not specified N/A Helicobacter pylori Review of systematic 
reviews 
Li (35) 2014 N/A Pregnancy N/A Toxoplasma gondii Systematic review 




Majidiani (42) 2016 Egypt, India, Iran Not specified N/A Toxoplasma Systematic review 
Man (80) 2011 Not specified N/A - review N/A Campylobacter spp. Review 
Micha (1) 2020 Global N/A N/A N/A Global Nutrition 
Report 
Mosites (11) 2017 N/A Children N/A Stunting Framework 
Muhsen (30) 2008 Alaska, India, Turkey, 
South Korea 
Children, adults N/A Helicobacter pylori Systematic review 
Navaneethan 
(76) 
2008 Not specified N/A - review N/A Infectious diarrhea Review 
Ng (32) 2018 Austria, Bangladesh, 
Canada, China, Egypt, 
Greece, Iran, Israel, 
Japan, Netherlands, 
Norway, Puerto Rico, 
USA 
Pregnant women N/A Helicobacter pylori Systematic review 
Oppong (7) 2020 Burkina Faso, Central 
African Republic, Congo, 
East Africa, Ethiopia, 
Gabon, Kenya, 
Madagascar, Namibia, 
Nigeria, Senegal, South 
Children < 5 
years 




Africa, Tanzania, West 
Africa 
Petri (18) 2008 Not specified Children N/A Enteric infections, diarrhea Not part of systematic 
search, only added for 
context 
Pflughoeft (50) 2012 N/A N/A N/A Microbiome in health and 
disease 
Not part of systematic 




2014 Zambia Children N/A Stunting Not part of systematic 
search, only added for 
context 
Qekwana (64) 2017 South Africa, urban Traditional 
slaughter 
practitioners 
Goat meat Occupational hazards Survey 
Radke (43) 2019 Belgium, Canada, China, 
Korea, Mexico, Thailand, 
United States 
Adults, children N/A Phthalate Systematic review 
Rahman (39) 2017 Bangladesh, Canada, 
Romania, United States 
Children N/A Arsenic Systematic review 
Richard (10) 2013 Bangladesh, Brazil, Peru, 
Guinea-Bissau 
Children ≤ 2 
years 





Rogawski (86) 2017 Bangladesh, India, 
Nepal, Pakistan, Brazil, 
Peru, South Africa, 
Tanzania 
 
Children N/A Enteroaggregative 
Escherichia coli 
Multicenter study 
Rogawski (86) 2017 LMIC N/A N/A Antibiotic exposure Review 
Roesel (65) 2014 Cote d’Ivoire, Ethiopia, 
Ghana, Kenya, Mali, 
Mozambique, South 
Africa, Tanzania 
N/A N/A Food safety in informal 
markets 
Review 




2013 N/A Pregnancy N/A Susceptibility to infectious 
disease 
Systematic review 
Scharf (85) 2014 Reference to GEMS 





and MAL-ED study in 
Bangladesh, Brazil, India, 




Nepal, Pakistan, Peru, 
South Africa, Tanzania 
Shirley (66) 2018 Global N/A N/A Amebiasis Global burden 
Smith (17) 2012 Low- and middle-income 
countries, not specified 
Children N/A Mycotoxins Review 
Solomons (19) 1993 N/A N/A N/A Gastrointestinal pathogens Not part of systematic 
search, only added for 
context 
Squire (59) 2017 Africa N/A N/A Cryptosporidium, Giardia Review 
Sugano (49) 2019 China, Colombia, Japan, 
Korea 
Not specified N/A Helicobacter pylori Systematic review 
Svendsen (67) 2019 Bangladesh, Canada, 
Croatia, Germany, Italy, 
New Zealand, Norway, 
Spain, United Kingdom, 
United States 
Adults, children N/A Post-infectious inflammatory 
bowel syndrome – various 
pathogens 
Systematic review 
Syed (16) 2018 Tanzania Children N/A Systemic inflammation Not part of systematic 







2011 Belgium, Canada, Korea, 
Netherlands, Spain, 
Sweden, United States 
Adults, children N/A Chemical hazards Systematic review 
Thiagarajah 
(77) 
2015 Not specified N/A - review N/A Secretory diarrhea Review 
Tran (34) 2015 Haiti, India, Nigeria, 
Pakistan, Peru, Senegal 
Pregnant women N/A Vibrio cholerae Systematic review 
Troeger (6) 2018 Global Children < 5 
years 
Not specified Disease and nutrition burden Global disease burden 
Welch (24) 2019 China, Bangladesh, Code 
d’Ivoire, Indonesia, 







N/A Helminths Systematic review 










N/A N/A N/A Biomarkers of iron and 
vitamin A status 
Not part of systematic 












2019 N/A N/A N/A Arsenic Technical document - 
Not part of systematic 















N/A N/A Children Helminths Deworming Guidance summary 





Appendix II. LITERATURE SEARCH STRATEGY 
Primary goals:  
- Synthesize available evidence in the literature regarding main impact pathways linking food safety 
or foodborne adverse health outcomes and nutrition outcomes, including biological/ biochemical 
mechanisms;  
- Identify gaps in current food safety literature and research needs. 
 
Search strategy 
- If/ where available: evidence from (systematic) reviews and/ or meta-analyses will be 
reported in lieu of original research articles. Reviews will be identified either through the 
search strategy (Pubmed and other sources) or through reviewing reference lists of 
considered articles.  
- Primary search in PubMed (s. Table 1) 
o Research topics identified from primary research papers in English language from year 
2000 onwards. 
- Articles cited by reviews will be considered on an individual basis if needed. 
- Other considered databases 
o IFPRI.com / ICRISAT.org – Key word: ‘Food safety’  
o Worldbank.com – Key word: “Food safety” 
o WHO.org – Health topics: ‘Food Safety’ à ‘Areas of work’ 
▪ Antimicrobial resistance in the food chain 
▪ Chemical risks 
▪ Foodborne diseases 
▪ Food hygiene 
▪ Food technologies 
▪ International Network of Food Safety Authorities (INFOSAN) 
▪ Microbiological risks 
▪ Nutrition and food security 
▪ Zoonoses and the environment 
Screening of all titles and potentially relevant abstracts from ‘List of Publications’ in 
each area. 
o CGIAR.org / CIAT.CGIAR.org – Screen all titles and potentially relevant abstracts of 
entire publication list (‘Research’ à ‘Publications’) 




o FAO.org – Screen titles and abstracts of all publications in ‘Food safety & quality’ à 
‘Resources’ 
o Worldfishcenter.org – Key word: ‘Food safety’ 
- Screening of ‘Reference’ lists of identified relevant articles à Screening of abstracts for 
potentially relevant titles. 
 
Screening process for all retrieved articles 
Decision process: Title screening > Abstract screening > Fulltext screening > In-/ exclusion 
In the screening process, the reviewer(s) will look for keywords as indicated in the PubMed search 
strategy.  
1) Title screening 
o Include: Titles indicating to cover aspects of both food safety and nutrition. 
o Exclude: Titles that are obviously not within the scope of the project. 
In case of doubt, move article to abstract review. 
2) Abstract screening for potentially relevant titles. 
Include if abstract appears to be of interest for the review, otherwise exclude. 
3) Fulltext screening for all titles remaining after title and abstract screening. 
a. Include if abstract appears to be of interest for the review. Make note in case the 
general topic is already extensively covered by a (systematic) review.  
b. Reference lists of relevant articles will be screened and potentially relevant references 
will be screened according to steps 2) and 3). 
 
Data extraction 
Data will be extracted for included articles (see Excel spreadsheet). 
 
Reporting 









PubMed search  
# Search string # of 
results  
Concept  
1 Food Safety[MeSH Terms] or Food Safe*[tiab] or Safe Food*[tiab] 
or Unsanitary Food*[tiab] or Insanitary Food*[tiab] or Sanitary 
Food*[tiab] or Food-Safe*[tiab] or Food-Safety-Hazard*[tiab] or 
Food Contaminat*[tiab] or Unsanitary Feed*[tiab] or Insanitary 
Feed*[tiab] or Sanitary Feed*[tiab] or Foodborn*[tiab] or Food-
born*[tiab] or Food born*[tiab] or Spoil*[tiab] or Food 
Hygien*[tiab] or Hygienic Food*[tiab] or Hygienic Practic*[tiab] 
or Hygiene-Food*[tiab] or Hygiene-Practic*[tiab] or Biological 
Hazard*[tiab] or Chemical Hazard*[tiab] or Physical Hazard*[tiab] 
or Food Hazard*[tiab] or Hazardous Food*[tiab] or Allergenic 
Hazard*[tiab] or Biological-Hazard*[tiab] or Chemical-
Hazard*[tiab] or Physical-Hazard*[tiab] or Allergenic-
Hazard*[tiab] or Food Pathogen*[tiab] or Pathogen in 
Food*[tiab] or Pathogens in Food*[tiab] or 
Foodborne zoono*[tiab] or Food-borne zoono*[tiab] or Food 
poison*[tiab] or Food-poison*[tiab] or Poisonous food*[tiab] or 
food handl*[tiab] or food-handl*[tiab] or Virus-commodit*[tiab] 















to food safety. 
2 Nutritional Status[MeSH Terms] or Malnutrition[MeSH Terms] or 
Diet, Food, and Nutrition[MeSH Terms] or Food*[tiab] or 
Nutritio*[tiab] or Eat*[tiab] or Drink*[tiab] or Foodstuff*[tiab] or 
Food-stuff*[tiab] or Aliment*[tiab] or Cook*[tiab] or Snack*[tiab] 
or Cuisine*[tiab] or Kitch*[tiab] or Meal*[tiab] or Nourish*[tiab] 
or Diet*[tiab] or Consum*[tiab] or Food Prepar*[tiab] or Stunted 
Growth*[tiab] or Underweight*[tiab] or Stunt*[tiab] or 
Wasted*[tiab] or Wasting*[tiab] or Thinness*[tiab] or 
micronutrient deficien*[tiab] or nutrient deficien*[tiab] or 
hidden hunger*[tiab] or hidden-hunger*[tiab] or hunger*[tiab] or 













3 LMIC*[tiab] or Low-income*[tiab] or Middle-income*[tiab] or 
Income*[tiab] or Low- and Middle-Income Countr*[tiab] or Low 
and Middle-Income Countr*[tiab] or Developing Countr*[tiab] or 
Developing nation*[tiab] or Rural*[tiab] or Remote*[tiab] or Less 
developed countr*[tiab] or Least developed countr*[tiab] or 
Under developed countr*[tiab] or Least developed populat*[tiab] 
or Under developed populat*[tiab] or Least developed 
nation*[tiab] or Under developed nation*[tiab] or Resource 
limit*[tiab] or Resource poor*[tiab] or Third World*[tiab] or 
Third-World*[tiab] or Developing-Countr*[tiab] or Developing-
nation*[tiab] or Less-developed countr*[tiab] or Least-developed 
countr*[tiab] or Under-developed countr*[tiab] or Least-
developed populat*[tiab] or Under-developed populat*[tiab] or 
Least-developed nation*[tiab] or Under-developed nation*[tiab] 
or Resource-limit*[tiab] or Resource-poor*[tiab] or Afri*[tiab] or 
Sahara*[tiab] or sub-sahara*[tiab] or Asia*[tiab] or Latino*[tiab] 
or Latina*[tiab] or Latin Americ*[tiab] or Latin-Americ*[tiab] or 
South America*[tiab] South-America*[tiab] or Carib*[tiab] or 
Carrib*[tiab] or Afghani*[tiab] or Albania*[tiab] or Algeria*[tiab] 
or Algier*[tiab] or Angola*[tiab] or Antigua*[tiab] or 
Argentin*[tiab] or Armenia*[tiab] or Azerbaijan*[tiab] or 
Bangladesh*[tiab] or Belarus*[tiab] or Beliz*[tiab] or Benin*[tiab] 
or Bhutan*[tiab] or Bolivia*[tiab] or Bosnia* and 
Herzegovina*[tiab] or Bosnia*[tiab] or Botswan*[tiab] or 
Batswan*[tiab] or Tswan*[tiab] or Brazil*[tiab] or Brasil*[tiab] or 
Burkina Faso*[tiab] or Burundi*[tiab] or Cabo *[tiab] or 
Cambodia*[tiab] or Cameroon*[tiab] or Central Africa*[tiab] or 
Chad*[tiab] or China*[tiab] or Chine*[tiab] or Chino*[tiab] or 
Colombia*[tiab] or Comoro*[tiab] or Congo*[tiab] or Cook 
Island*[tiab] or Costa Rica*[tiab] or Côte d'Ivoir*[tiab] or Ivori* 
Cuba*[tiab] or Djibouti*[tiab] or Dominica*[tiab] or Dominican 
Republic*[tiab] or Ecuador*[tiab] or Egypt*[tiab] or El 
Salvador*[tiab] or Equatorial Guinea*[tiab] or Eritrea*[tiab] or 
Ethiopia*[tiab] or Fiji*[tiab] or Gabon*[tiab] or Gambia*[tiab] or 





Georgia*[tiab] or Ghana*[tiab] or Grenada*[tiab] or Guam*[tiab] 
or Guatemala*[tiab] or Guinea*[tiab] or Guyana*[tiab] or 
Haiti*[tiab] or Hondura*[tiab] or India*[tiab] or Indonesia*[tiab] 
or Iran*[tiab] or Iraq*[tiab] or Jamaica*[tiab] or Jordan*[tiab] or 
Kazakh*[tiab] or Kenya*[tiab] or Kenia*[tiab] Kiribat*[tiab] or 
Korea*[tiab] or Kosov*[tiab] or Kyrgy*[tiab] or Lao*[tiab] or 
Leban*[tiab] or Liban*[tiab] or Lesotho*[tiab] or Liberia*[tiab] or 
Libya*[tiab] or Lybia*[tiab] or Macedoni*[tiab] or Madagas*[tiab] 
or Malawi*[tiab] or Malaysia*[tiab] or Maldiv*[tiab] or 
Mali*[tiab] or Marian*[tiab] or Marshall*[tiab] or Maurit*[tiab] 
or Mexic*[tiab] or Micrones*[tiab] or Moldo*[tiab] or 
Mongol*[tiab] or Montenegr*[tiab] or Montserrat*[tiab] or 
Morocc*[tiab] or Mozambiqu*[tiab] or Myanmar*[tiab] or 
Burme*[tiab] or Democratic Republic*[tiab] or Democratic-
Republic*[tiab] or Republic*[tiab] or Burma*[tiab] or 
Namibia*[tiab] or Nauru*[tiab] or Nepal*[tiab] or 
Nicaragua*[tiab] or Niger*[tiab] or Nigeria*[tiab] or Niue*[tiab] 
or Pakistan*[tiab] or Palau*[tiab] or Panam*[tiab] or 
Paraguay*[tiab] or Peru*[tiab] or Philippi*[tiab] or Philipi*[tiab] 
or Puerto*[tiab] or Rwand*[tiab] or Ruand*[tiab] or Saint*[tiab] 
or Samo*[tiab] or São Tom*[tiab] or Sao Tom*[tiab] or 
Senegal*[tiab] or Serbi*[tiab] or Sierra Leon*[tiab] or Sierra-
Leon*[tiab] or Solomon*[tiab] or Somali*[tiab] or South 
Africa*[tiab] or South Sudan*[tiab] or Sri Lank*[tiab] or Sri-
Lank*[tiab] or Sudan*[tiab] or Surinam*[tiab] or Swaziland*[tiab] 
or Syria*[tiab] or Tajikistan*[tiab] or Tanzania*[tiab] or 
Thai*[tiab] or Timor *[tiab] or Togo*[tiab] or Tokelau*[tiab] or 
Tonga*[tiab] or Tunisia*[tiab] or Turk*[tiab] or Turkmeni*[tiab] 
or Tuvalu*[tiab] or Uganda*[tiab] or Ukrain*[tiab] or 
Uzbek*[tiab] or Vanuat*[tiab] or Venezuel*[tiab] or 
Vietnam*[tiab] or Virgin*[tiab] or Wallis*[tiab] or West 
Bank*[tiab] or West-Bank*[tiab] or Gaza*[tiab] or Ghaza*[tiab] or 
Palestin*[tiab] or Palaestin*[tiab] or Yemen*[tiab] or 




or Middle East*[tiab] or Middle-East*[tiab] or Health 
Development Inde*[tiab] or Ngwa*[tiab] or Development 
Inde*[tiab] or Austrones*[tiab] or Ceylon*[tiab] or Hong 
Kong*[tiab] or Taiwan*[tiab] or Poor household*[tiab] or 
Disadvantaged nation*[tiab] or Poor nation*[tiab] or 
Disadvantaged household*[tiab] or Poor societ*[tiab] or 
Disadvantaged societ*[tiab] or Poor count*[tiab] or 
disadvantaged count*[tiab] or vulnerable nation*[tiab] or 
vulnerable household*[tiab] or vulnerable societ*[tiab] or Poor 
econom*[tiab] or disadvantaged econom*[tiab] or vulnerable 
econom*[tiab] or Low- and Middle-Income Econom*[tiab] or Low 
and Middle-Income Econom*[tiab] or Developing Econom*[tiab] 
or Less developed Econom*[tiab] or Least developed 
Econom*[tiab] or Under developed Econom*[tiab] 
4 #1 AND #2 AND #3  
Note: Only articles from the combined search (#4) were 
screened. 
8323 Combination 
 
 
